Pooya Saberi

CEO

Pooya Saberi picture

Pooya Saberi

Sensoreal

CEO

Sensoreal is an early-stage medtech startup developing instrument-free products to monitor the immune response from a few drops of blood in less than 15 minutes. In a significant improvement over lateral flow tests, our capillary circuits enable sensitive, quantitative detection of low abundance proteins. As an example of one target application, our technology was successfully deployed on the International Space Station in 2019 to simultaneously measure five cytokines in a single device. Sensoreal is funded by Health Canada and collaborating with the Research Institute of St. Joe’s to develop a rapid pathogen-agnostic test to differentiate bacterial and viral infections and to help physicians guide treatment and antibiotic therapy.